J. Stephen Nix
Researcher
Also affiliated: Walmart (United States) (2025); Johns Hopkins University (2018–2021); University of Arkansas Medical Center (2023); Johns Hopkins Medicine (2019–2021); Department for Transport (2025); International Association of Public Transport (2025); Johns Hopkins Hospital (2024); Alice L. Walton School of Medicine (2025)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
J. Stephen Nix's research focuses on neuropathology and the molecular diagnosis of brain tumors. He has published on various aspects of tumor pathology, including the significance of staining intensity in Ki-67 proliferation index in meningiomas and the practical considerations for molecular diagnostics in brain tumors. His work also investigates specific genetic alterations in cancers, such as DEK-AFF2 carcinoma and SMARCA4-deficient central nervous system metastases. Nix has explored the utility of advanced sequencing techniques, including long-read sequencing, for brain tumor analysis and has contributed to understanding rare tumor presentations through case series and systematic reviews. His research network includes collaborators such as Murat Gökden, William J. Shelton, Analiz Rodriguez, and Erika Horta, with whom he has co-authored multiple publications.
Metrics
- h-index: 9
- Publications: 32
- Citations: 410
Selected Publications
-
Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models (2025)
-
Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model (2025)
-
Case 333: Masson Tumor (2025)
-
Case 333 (2024)
-
Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case (2024)
-
Long-read sequencing for brain tumors (2024)
-
Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment. (2024)
-
A rare case of atypical intradural extramedullary glioblastoma diagnosed utilizing next-generation sequencing and methylation profiling: illustrative case (2024)
-
Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case (2024)
-
Basal cell carcinoma appearing to emanate from the punctum (2024)
-
Radiologic-pathologic autopsy correlation of an internal watershed infarct, a case report (2023)
-
Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland (2023)
-
BAP1-loss in the salivary duct carcinoma component of an intracapsular carcinoma ex pleomorphic adenoma of the parotid gland (2023)
-
Miyoshi Muscular Dystrophy Due to Novel Splice Site Variants in <i>DYSF</i> Gene (2022)
-
A preliminary PET evaluation of dodecafluoropentane emulsion effects on rabbit brain hypoxia in stroke (2015)
Collaboration Network
Top Collaborators
- Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment.
- Miyoshi Muscular Dystrophy Due to Novel Splice Site Variants in <i>DYSF</i> Gene
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- A rare case of atypical intradural extramedullary glioblastoma diagnosed utilizing next-generation sequencing and methylation profiling: illustrative case
- Long-read sequencing for brain tumors
Showing 5 of 6 shared publications
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- A rare case of atypical intradural extramedullary glioblastoma diagnosed utilizing next-generation sequencing and methylation profiling: illustrative case
- Long-read sequencing for brain tumors
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- A rare case of atypical intradural extramedullary glioblastoma diagnosed utilizing next-generation sequencing and methylation profiling: illustrative case
- Long-read sequencing for brain tumors
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case
- Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland
- BAP1-loss in the salivary duct carcinoma component of an intracapsular carcinoma ex pleomorphic adenoma of the parotid gland
- Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland
- BAP1-loss in the salivary duct carcinoma component of an intracapsular carcinoma ex pleomorphic adenoma of the parotid gland
- Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland
- BAP1-loss in the salivary duct carcinoma component of an intracapsular carcinoma ex pleomorphic adenoma of the parotid gland
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- A rare case of atypical intradural extramedullary glioblastoma diagnosed utilizing next-generation sequencing and methylation profiling: illustrative case
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case
- Case 333
- Case 333: Masson Tumor
- Case 333
- Case 333: Masson Tumor
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
- Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
- Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
- Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
- Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
- Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models
Similar Researchers
Based on overlapping research topics